10 February 2022 : Clinical Research
A Single-Center, Randomized, Double-Blind Study of 94 Patients Undergoing Surgery for Cerebral Glioma to Compare Postoperative Thromboprophylaxis with and without Rivaroxaban
Zi-Yan Wang1ABC, You-Dong Wan2CDEF, Xian-Zhi Liu1EFG, Hao Wang1AD, Guang-Yi Jiang1ABF, Bo Yang1ABCDEFG*DOI: 10.12659/MSM.934341
Med Sci Monit 2022; 28:e934341
Figure 2 Comparison of incidence of VTE between rivaroxaban and placebo groups.